Your browser is no longer supported. Please, upgrade your browser.
Settings
ZIOP ZIOPHARM Oncology, Inc. daily Stock Chart
ZIOP [NASD]
ZIOPHARM Oncology, Inc.
Index- P/E- EPS (ttm)-0.54 Insider Own1.70% Shs Outstand154.54M Perf Week8.82%
Market Cap400.26M Forward P/E- EPS next Y-0.32 Insider Trans0.00% Shs Float154.54M Perf Month11.64%
Income-75.60M PEG- EPS next Q-0.11 Inst Own44.90% Short Float26.28% Perf Quarter-4.07%
Sales1.70M P/S235.45 EPS this Y59.50% Inst Trans25.79% Short Ratio20.13 Perf Half Y1.17%
Book/sh-1.11 P/B- EPS next Y37.30% ROA-89.90% Target Price4.50 Perf Year-34.26%
Cash/sh0.21 P/C12.63 EPS next 5Y- ROE58.60% 52W Range1.56 - 5.00 Perf YTD38.50%
Dividend- P/FCF- EPS past 5Y15.30% ROI55.30% 52W High-48.20% Beta2.47
Dividend %- Quick Ratio0.80 Sales past 5Y51.50% Gross Margin- 52W Low66.03% ATR0.17
Employees46 Current Ratio0.80 Sales Q/Q- Oper. Margin- RSI (14)59.73 Volatility6.63% 7.63%
OptionableYes Debt/Eq- EPS Q/Q-5.60% Profit Margin- Rel Volume0.70 Prev Close2.57
ShortableYes LT Debt/Eq- EarningsFeb 28 AMC Payout- Avg Volume2.02M Price2.59
Recom2.80 SMA2014.58% SMA509.50% SMA200-13.04% Volume1,411,182 Change0.78%
Nov-15-18Upgrade Raymond James Mkt Perform → Outperform
Jun-18-18Downgrade JP Morgan Neutral → Underweight
Jun-01-17Initiated H.C. Wainwright Buy $9.50
Aug-10-16Upgrade Wells Fargo Underperform → Market Perform
Jul-19-16Reiterated Mizuho Neutral $7 → $5
Jun-02-16Initiated Raymond James Mkt Perform
May-11-16Reiterated Mizuho Neutral $6 → $7
Jan-25-16Reiterated Mizuho Neutral $10 → $6
Dec-04-15Initiated Wells Fargo Underperform
Jun-10-15Reiterated Mizuho Neutral $14 → $10
Mar-10-15Downgrade Mizuho Buy → Neutral $14
Mar-02-15Reiterated Mizuho Buy $11 → $14
Mar-20-14Initiated Mizuho Buy $11
Apr-02-12Reiterated Griffin Securities Buy $9 → $12
Mar-26-12Initiated Canaccord Genuity Buy $9
Dec-15-11Initiated Global Hunter Securities Buy $9
Nov-22-11Initiated Collins Stewart Buy $9
Feb-23-11Initiated Barclays Capital Overweight $9
Feb-08-11Reiterated Dawson James Buy $6 → $8
Aug-02-10Initiated Dawson James Buy $6
Feb-14-19 08:30AM  Recent Analysis Shows Lattice Semiconductor, ZIOPHARM Oncology, Ferro, SYNNEX, AxoGen, and Twin Disc Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Feb-13-19 06:49AM  Is ZIOPHARM Oncology, Inc.s (NASDAQ:ZIOP) CEO Paid At A Competitive Rate? Simply Wall St.
Feb-11-19 07:45AM  Ziopharm Oncology Completes Enrollment of Controlled IL-12 Monotherapy Expansion Substudy in Phase 1 Brain Cancer Trial GlobeNewswire
Feb-01-19 07:30AM  The Unknown Biotech Play that Could Deliver 400% Returns, or Much More ACCESSWIRE
Jan-21-19 09:00AM  Biotech Stocks on the Move ACCESSWIRE
Jan-07-19 04:01PM  Ziopharm Oncology Posts Letter to Stockholders GlobeNewswire
Dec-28-18 08:52AM  Ziopharm Oncology (ZIOP) in Focus: Stock Moves 6.2% Higher Zacks
Dec-27-18 01:16PM  Ziopharm Oncology Responds to Recent Stock Decline and Clarifies Exclusivity Rights for Clinical Assets GlobeNewswire +6.21%
12:45PM  4 Healthcare Stocks That Could Test December Highs ACCESSWIRE
Dec-23-18 09:26PM  Do Hedge Funds Love ZIOPHARM Oncology Inc. (ZIOP)? Insider Monkey
Dec-21-18 09:15AM  Is the Options Market Predicting a Spike in Ziopharm Oncology (ZIOP) Stock? Zacks -7.44%
08:00AM  Ziopharm Oncology to Present at the 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-19-18 06:59AM  Ziopharm Oncology and TriArm Therapeutics Establish Joint Venture to Develop and Commercialize Sleeping Beauty CAR T in China, Taiwan and Korea GlobeNewswire -5.35%
Dec-14-18 07:47AM  The Daily Biotech Pulse: Axovant In-Licenses 2 Gene Therapies, Agile To Undertake Additional Study Of Contraceptive Patch Benzinga
Dec-13-18 04:15PM  Ziopharm Oncology Promotes Dr. David Mauney to President GlobeNewswire
Dec-04-18 08:17PM  Edited Transcript of ZIOP earnings conference call or presentation 12-Nov-18 1:00pm GMT Thomson Reuters StreetEvents -5.69%
Dec-03-18 07:25AM  Market Trends Toward New Normal in Zillow Group, YRC Worldwide, The Home Depot, UROGEN PHARMA, ZIOPHARM Oncology, and Cinedigm Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Nov-29-18 08:40AM  Are Options Traders Betting on a Big Move in ZIOPHARM Oncology (ZIOP) Stock? Zacks -9.12%
Nov-16-18 02:30PM  Ziopharm Oncology Provides Controlled IL-12 Update with Positive Data from Phase 1 Trial Presented at Annual Meeting of the Society for Neuro-Oncology GlobeNewswire
08:08AM  The Daily Biotech Pulse: Mallinckrodt FDA Verdict, European Cheer For Bristol-Myers Squibb, Morphosys Clinches Licensing Deal Benzinga
Nov-14-18 09:15AM  Biotech Stock Roundup: Gilead, Regeneron Present Data, Cocrystal Pharma Surges Zacks
Nov-13-18 02:10PM  Ziopharm Oncology (ZIOP) Reports Q3 Loss, Lags Revenue Estimates Zacks +16.38%
Nov-12-18 07:01AM  Ziopharm Oncology to Host Conference Call Today at 8 a.m. GlobeNewswire -7.57%
07:00AM  Ziopharm Oncology Announces Immuno-oncology Clinical Supply Agreement with Regeneron to Evaluate Combination Therapy for Patients with Brain Cancer GlobeNewswire
06:58AM  Ziopharm Oncology Announces $50 Million Private Placement GlobeNewswire
Nov-11-18 10:01AM  Is ZIOPHARM Oncology Inc (NASDAQ:ZIOP) A Financially Sound Company? Simply Wall St.
Nov-09-18 02:08PM  Intrexon (XON) Reports Narrower-Than-Expected Loss in Q3 Zacks
Nov-08-18 04:01PM  Ziopharm Oncology Third Quarter 2018 Financial Results Conference Call Rescheduled to Nov. 12 GlobeNewswire
Nov-07-18 04:02PM  Ziopharm Oncology to Present at the Stifel 2018 Healthcare Conference on Nov. 14 GlobeNewswire +8.33%
Nov-05-18 07:00AM  Ziopharm Oncology to Present Update on Controlled IL-12 Brain Cancer Trial at Annual Meeting of the Society for Neuro-Oncology on Nov. 16 GlobeNewswire
Oct-31-18 04:30PM  Ziopharm Oncology to Announce Third Quarter 2018 Financial Results, Host Conference Call Nov. 8 GlobeNewswire
Oct-29-18 10:31AM  Ziopharm Oncology (ZIOP) Q3 Earnings Preview: What's Shaping Up? Zacks -8.37%
Oct-26-18 08:49AM  Implied Volatility Surging for ZIOPHARM Oncology (ZIOP) Stock Options Zacks
Oct-24-18 07:25AM  Report: Developing Opportunities within Univar, Aqua America, Chimerix, Superior Energy Services, TechTarget, and ZIOPHARM Oncology Future Expectations, Projections Moving into 2018 GlobeNewswire -6.82%
Oct-16-18 04:01PM  Ziopharm Oncology Announces Changes to Board of Directors and Management Team GlobeNewswire +8.47%
Oct-09-18 07:00AM  Ziopharm and Precigen Redefine Relationships, Announce New License Agreement GlobeNewswire
Sep-25-18 07:30AM  Ziopharm Oncology to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-20-18 08:36AM  Should You Have ZIOPHARM Oncology Incs (NASDAQ:ZIOP) In Your Portfolio? Simply Wall St. +7.02%
Sep-19-18 08:55AM  Is the Options Market Predicting a Spike in ZIOPHARM Oncology (ZIOP) Stock? Zacks
Sep-04-18 09:15AM  CORRECTING and REPLACING -- Ziopharm Oncology Announces Scott Braunstein, M.D., Operating Partner at Aisling Capital, Nominated to Board of Directors GlobeNewswire
07:30AM  Ziopharm Oncology Announces Scott Braunstein, M.D., Operating Partner at Aisling Capital, Nominated to Board of Directors GlobeNewswire
Aug-22-18 07:50PM  Edited Transcript of ZIOP earnings conference call or presentation 8-Aug-18 8:30pm GMT Thomson Reuters StreetEvents -7.33%
Aug-14-18 07:57AM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Ziopharm Oncology, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire -5.90%
Aug-11-18 07:03AM  3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool
Aug-09-18 03:36PM  Why Ziopharm Oncology Is Soaring 14% Today Motley Fool +10.76%
Aug-08-18 07:35PM  Ziopharm Oncology (ZIOP) Reports Q2 Loss, Lags Revenue Estimates Zacks -5.64%
06:32PM  Ziopharm: 2Q Earnings Snapshot Associated Press
04:01PM  Ziopharm Oncology Reports Second Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
02:30PM  ZIOPHARM Oncology, Inc. to Host Earnings Call ACCESSWIRE
Aug-07-18 04:00PM  Why Ziopharm Oncology Stock Zoomed 16.8% Higher Today Motley Fool +17.70%
07:30AM  Ziopharm Oncology Announces Changes to its Board of Directors GlobeNewswire
Jul-31-18 07:45AM  Ziopharm Oncology to Announce Second Quarter 2018 Financial Results, Host Conference Call Aug. 8 GlobeNewswire +6.15%
Jul-30-18 07:20AM  Breakfast Technical Briefing on ZIOPHARM Oncology and Three Other Additional Biotech Stocks ACCESSWIRE
Jul-26-18 12:05PM  Ziopharm Oncology Board Responds to Recent Stock Price Decline GlobeNewswire
Jul-19-18 08:24AM  Why Ziopharm Oncology Stock Fell by 27% Halfway Through 2018 Motley Fool
Jul-02-18 07:25AM  Initiating Free Research Reports on ZIOPHARM Oncology and Three Other Biotech Equities ACCESSWIRE
Jun-29-18 08:17AM  Better Buy: Ziopharm Oncology, Inc. vs. Celldex Therapeutics Motley Fool
07:55AM  Investor Expectations to Drive Momentum within ZIOPHARM Oncology, MedEquities Realty Trust, Argan, Churchill Downs, Tyson Foods, and Acadia Realty Trust Discovering Underlying Factors of Influence GlobeNewswire
Jun-28-18 04:01PM  Ziopharm Oncology Enrolls First Patient in Phase 1 Trial Evaluating Combination Therapy of Controlled IL-12 and OPDIVO® GlobeNewswire
Jun-20-18 08:32AM  Biotech Stock Roundup: SRPT & SLDB Soar on Positive Data, ANIK & ZIOP Crash Zacks +5.88%
Jun-19-18 08:00AM  Todays Research Reports on Stocks to Watch: Arrowhead Pharmaceuticals and ZIOPHARM Oncology ACCESSWIRE
Jun-18-18 04:10PM  Why Ziopharm Oncology is Crashing by 17.7% Today Motley Fool -18.37%
07:43AM  Ziopharm Oncology shares slide 7% premarket after FDA places clinical hold on cancer trial MarketWatch
07:30AM  Ziopharm Oncology Reports on Status of Investigational New Drug Application for Phase 1 Trial to Evaluate CD19-targeted CAR T Therapy GlobeNewswire
Jun-17-18 07:17AM  Is Ziopharm Oncology Inc. a Buy? Motley Fool
Jun-09-18 02:01PM  Why ZIOPHARM Oncology, Inc. Stock Broke Out in May Motley Fool
Jun-05-18 07:40AM  Complimentary Technical Snapshots on Viking Therapeutics and Three More Biotech Stocks ACCESSWIRE
Jun-04-18 07:56AM  Ziopharm Oncology Presents Clinical Data Demonstrating Anti-tumor Immune Response of Controlled IL-12 Platform in Breast Cancer and Glioblastoma at American Society of Clinical Oncology (ASCO) Annual Meeting GlobeNewswire -8.59%
May-31-18 08:20AM  Today's Research Reports on Trending Tickers: Sangamo Therapeutics and ZIOPHARM Oncology ACCESSWIRE
May-23-18 01:53AM  Edited Transcript of ZIOP earnings conference call or presentation 10-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-16-18 05:00PM  Ziopharm Oncology to Present Data from Clinical Studies of Controlled IL-12 in Breast Cancer and Glioblastoma at American Society of Clinical Oncology (ASCO) Annual Meeting GlobeNewswire
08:00AM  New Research: Key Drivers of Growth for root9B Holdings Inc., Comfort Systems, SS&C Technologies, ZIOPHARM Oncology, L Brands, and QEP Resources Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
May-12-18 07:16AM  Better Buy: Ziopharm Oncology, Inc. vs. bluebird bio Inc. Motley Fool
May-11-18 04:00PM  Here's What's Causing Intrexon to Tumble 20% Today Motley Fool
May-10-18 05:34PM  Ziopharm: 1Q Earnings Snapshot Associated Press
04:01PM  Ziopharm Oncology Reports First Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
May-02-18 07:57AM  Ziopharm Oncology to Announce First Quarter 2018 Financial Results, Host Conference Call May 10 GlobeNewswire
Apr-03-18 02:45PM  Is Ziopharm Oncology, Inc. a Buy? Motley Fool +8.31%
Mar-09-18 07:45AM  New Research Coverage Highlights Great Western, Acadia Realty Trust, Interpace Diagnostics Group, Abercrombie & Fitch, United Rentals, and ZIOPHARM Oncology Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire +5.34%
Mar-05-18 06:15PM  Edited Transcript of ZIOP earnings conference call or presentation 1-Mar-18 9:30pm GMT Thomson Reuters StreetEvents
Mar-02-18 12:32PM  Intrexon (XON) Q4 Loss Narrower Than Expected, Revenues Beat Zacks +11.60%
Mar-01-18 04:59PM  Ziopharm reports 4Q loss Associated Press
04:01PM  Ziopharm Oncology Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update GlobeNewswire
12:00PM  ZIOPHARM Oncology, Inc. to Host Earnings Call ACCESSWIRE
Feb-14-18 07:30AM  Wired News Ziopharm Oncology Presents Data on Rapid Production of CAR T Cells at Keystone Symposia ACCESSWIRE
Feb-13-18 07:15AM  Ziopharm Oncology to Announce Fourth Quarter and Full Year 2017 Year-end Financial Results and Host Conference Call on March 1 GlobeNewswire
Feb-12-18 07:00AM  Ziopharm Oncology Presents Data on Very Rapid Production of CAR T Cells at Keystone Symposia Emerging Cellular Therapies: T Cells and Beyond GlobeNewswire
Feb-06-18 12:14PM  Ziopharm stock rallies after company says nothing to see here, folks MarketWatch +15.90%
08:55AM  Ziopharm Oncology Addresses Rumors and Stock Volatility, Affirms 2018 Guidance GlobeNewswire
Jan-24-18 02:35PM  Behind Celgenes Strategy in the Juno Therapeutics Acquisition Market Realist -5.93%
Jan-23-18 08:10AM  Todays Research Reports on Trending Tickers: Spectrum Pharmaceuticals and ZIOPHARM Oncology ACCESSWIRE
Jan-22-18 06:00PM  Did ZIOPHARM Oncology Incs (NASDAQ:ZIOP) Earnings Growth Outperform The Industry? Simply Wall St. +20.09%
Jan-17-18 07:30AM  Could Little Known Orgenesis (ORGS) Become A Dominant Player in The Multi Billion Dollar Cell Therapy Market? ACCESSWIRE
Jan-11-18 07:30AM  Blog Exposure - ZIOPHARM Updated on Key Clinical Programs and Corporate Development Activities ACCESSWIRE
Jan-09-18 07:00AM  Ziopharm Oncology Provides Update on Standout Technologies during the 36th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-28-17 12:46PM  ETFs with exposure to ZIOPHARM Oncology, Inc. : December 28, 2017 Capital Cube
Dec-27-17 08:50AM  ZIOPHARM Oncology, Inc. :ZIOP-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017 Capital Cube
Dec-21-17 04:05PM  ZIOPHARM to Present at the 36th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Nov-30-17 09:19AM  Better Buy: Ziopharm Oncology Inc. vs. Celldex Therapeutics, Inc. Motley Fool
Nov-28-17 08:25AM  Detailed Research: Economic Perspectives on eBay, Maxwell Technologies, The Priceline Group, Allscripts Healthcare Solutions, Ziopharm Oncology, and H&R Block What Drives Growth in Today's Competitive Landscape GlobeNewswire
ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing a portfolio of immuno-oncology therapies for treating heterogenous solid tumors and unknown antigens. The company develops two immuno-oncology platform technologies, including Controlled IL-12, which delivers interleukin 12 or IL-12, a master regular of the immune system, in a controlled and safe manner to focus the patient's immune system to cancer; and Sleeping Beauty (SB), which is based on the genetic engineering of T-cells using the (SB) system to rapidly reprogram T-cells outside of the body for infusion. Its lead gene therapy product candidate is Ad-RTS-hIL-12 plus veledimex, which is in Phase I clinical trial, a gene therapy product candidate to treat patients with recurrent glioblastoma. The company is also developing chimeric antigen receptor (CAR) T-cell and T-cell receptor T-cell therapies. ZIOPHARM Oncology, Inc. has collaboration agreements with Precigen, Inc., MD Anderson Cancer Center, the National Cancer Institute, and Ares Trading S.A. The company is headquartered in Boston, Massachusetts.